Announcement Regarding the Acceptance of Two DFP-10917 Clinical Study Presentations at ASH 2026
Filed with TSE · · 1 page · English
Earlier from Delta-Fly Pharma
- Update on the Phase 2/3 Clinical Trial of DFP-17729
- Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 with Venetoclax
- Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax
- Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
- Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
Later from Delta-Fly Pharma
All Delta-Fly Pharma news releasesFollow Delta-Fly Pharma into a list and get an email when it puts out news.
Follow Delta-Fly Pharma